Follow Us

Erin Borger Appointed as CEO of ExThera Medical Corporation, Bringing Finance and Healthcare Expertise

Share This Post

Key Highlights

  • Erin Borger assumes CEO role at ExThera Medical Corporation, succeeding Robert Ward.
  • Borger brings 20 years of experience in finance, including leadership roles at UBS and Morgan Stanley.
  • ExThera focuses on advancing technologies in oncology, sepsis, and COVID-19, with Erin Borger set to drive global commercialization and clinical trials.

Source: Business Wire

Notable Quotes

  • “I am honored to have the once in a lifetime opportunity to lead ExThera’s mission to save lives… ExThera has the opportunity to change the way we think about infectious disease and oncology.” – Erin Borger, CEO at ExThera Medical Corporation
  • “We are excited to have Erin build out the team. His ability to seek out and recruit top professionals will take ExThera to the next level.” – Robert Ward, Chairman, President, and Founder at ExThera

SoH's Take

The appointment of Erin Borger as CEO of ExThera Medical Corporation marks a significant milestone in the company’s journey. Borger’s extensive experience in finance and strategic growth, particularly in the healthcare sector, positions him uniquely to steer ExThera towards new heights. His proven track record in leadership and business stabilization, combined with his deep understanding of the healthcare landscape, aligns perfectly with ExThera’s mission to revolutionize healthcare technology. Under Borger’s guidance, ExThera is likely to see accelerated progress in global commercialization and clinical trials, further advancing their innovative technologies in critical areas like oncology and infectious diseases. This strategic leadership change promises to enhance ExThera’s impact in the medical technology field, potentially setting new benchmarks for success and innovation.

More To Explore

Total
0
Share
0
0
0
0
0
0